XNAS: ELVN
Enliven Therapeutics Inc Live Stock Price Today, Share Analysis and Chart
about
Enliven Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery and development of small molecule therapeutics. The product candidates of the company include ELVN-001 is designed to specifically target the BCR-ABL fusi...
Read More
41.70
0.47
(1.14%)
542.2K
XNAS Volume
XNAS 01 May, 2026 5:30 PM (EDT)
Board Meeting
The next board meeting for Enliven Therapeutics Inc is on 14 May 2026 for the purpose of Enliven Therapeutics Inc First Quarter Earnings Results for 2026
See details
Not Eligible
Expensive Valuation
Technically Moderately Bullish
Enliven Therapeutics Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..